IMARC Group’s latest research report, titled “Pain Management Drugs Market Research: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
The global pain management drugs market reached a value of US$ 65.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 82.1 Billion by 2027, exhibiting a CAGR of 3.8% during 2022-2027. Pain management drugs reduce or relieve arthritis, headaches, sore muscles, or other aches and pains. These drugs help ease the suffering of individuals experiencing pain, whether acute pain or chronic, along with their quality of life. Various drugs are prescribed to manage pain symptoms resulting from inflammation in response to tissue damage, chemical agents, or nerve damage.
Get Free Sample Copy of Report at – https://www.imarcgroup.com/pain-management-drugs-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by drug class, indication and distribution channel.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Pain Management Drugs Market
- Strategies of major players and product offerings
Global Pain Management Drugs Market Trends:
The global market is primarily driven by the growing geriatric population that is more susceptible to developing joint pain and other chronic conditions. Furthermore, the rising prevalence of chronic diseases, such as cancer, diabetic neuropathy, and osteoarthritis, is propelling the market growth. Apart from this, recent advancements in novel molecule combinations and drug delivery techniques, such as the introduction of intrathecal drug delivery that is expected to offer lucrative opportunities to market players across the globe, is providing a boost to the market growth. Moreover, rising healthcare expenditure and increasing government support are catalyzing the market growth. Besides this, the growing demand for opioids for neuropathic pain management is further creating a positive outlook for the market.
Top Companies Pain Management Drugs Industry:
- Abbott Laboratories, Inc
- Pfizer, Inc.
- Eli Lilly & Company
- Endo International plc
- F. Hoffmann-La Roche AG
- Bausch Health Companies, Inc.
- Merck & Co. Inc.
- Allergen Inc.
- Novartis International AG
- Johnson & Johnson Private Limited
- GlaxoSmithKline Plc
- Purdue Pharma L.P.
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/pain-management-drugs-market
COVID-19 Impact Overview:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Key Market Segmentation:
Market Breakup by Drug Class:
- NSAIDs
- Anesthetics
- Anticonvulsants
- Antimigraine Agents
- Antidepressants
- Opioids
- Others
Market Breakup by Indication:
- Musculoskeletal Pain
- Surgical and Trauma Pain
- Cancer Pain
- Neuropathic Pain
- Migraine Pain
- Obstetrical Pain
- Fibromyalgia Pain
- Burn Pain
- Dental/Facial Pain
- Pediatric Pain
- Others
Market Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
TOC for the Pain Management Drugs Market Research Report:
- Preface
- Scope and Methodology
- Executive Summary
- Introduction
- Global Pain Management Drugs Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
